NCT01708044: Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM |
|
|
| Completed | 1 | 32 | US | Pramlintide acetate, Placebo | AstraZeneca, Juvenile Diabetes Research Foundation | Type 1 Diabetes | 09/13 | 09/13 | | |
NCT02500979: Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus |
|
|
| Completed | 1 | 34 | US | Pramlintide acetate, Pramlintide: SYMLIN, Placebo, Lispro insulin U-100, Humalog insulin lispro U-100, Regular insulin U-100, Humulin R; U-100 | AstraZeneca, Juvenile Diabetes Research Foundation | Type 1 Diabetes Mellitus | 08/16 | 08/16 | | |
